The Journal of Organic Chemistry
Article
19.7, 14.4; HR-MS (ESI) calcd for C54H50O2 [M+] 730.3806, found
730.3825.
brine (100 mL), dried over anhydrous Na2SO4, and concentrated to
give the crude product, which contained excess benzyl alcohol. It was
directly hydrolyzed without further purification.
Compound 12. To a solution of the acid 11 (719 mg, 1.25 mmol)
in MeOH (60 mL) was added concentrated H2SO4 (0.7 mL). The
solution was refluxed for 15 h and cooled to rt. The solvent was
evaporated, and water (50 mL) was added. The product was extracted
with CH2Cl2 (3 × 50 mL). The combined organic extracts were dried
over anhydrous Na2SO4 and concentrated to give crude product.
Purification by flash column chromatography (10% CH2Cl2, 8%
EtOAc in hexane) provided the methyl ester 12 (600 mg, 77%):1H
NMR (400 MHz, CDCl3) δ 8.09−7.80 (m, 6H), 7.72−7.49 (m, 2H),
7.31−7.25 (m, 6H), 7.06−6.83 (m, 2H), 3.92 (s, 9H); 13C NMR (101
MHz, CDCl3) δ 166.8, 150.3, 145.0, 137.4, 132.9, 130.9, 129.5, 128.7,
92.9, 65.4, 52.4. The NMR data were consistent with the literature
report by Anderson.59
Compound 13. A solution of 1-tetradecene (485 mg, 2.47 mmol)
in THF (2 mL) was stirred and cooled to 0 °C. 9-BBN (4.94 mL, 0.5
M solution in THF) was added dropwise, and the solution was slowly
warmed to rt. After stirring at rt for 6 h, Pd(PPh3)4 (95 mg, 0.08
mmol) and K2CO3 (453 mg, 3.28 mmol) were added followed by
compound 12 (1.02 g, 1.64 mmol) in DMF (5 mL). The mixture was
heated at 50 °C for 16 h and then cooled to rt. Water (60 mL) was
added, and the reaction mixture was extracted with EtOAc (3 × 60
mL). The combined organic extracts were washed with water (3 × 60
mL) and brine (60 mL), dried over anhydrous Na2SO4, and
concentrated to give the crude product. The residue was purified by
flash column chromatography (10% EtOAc, 10% CH2Cl2 in hexane)
to give the product 13 as a yellow solid (840 mg, 74%): 1H NMR (400
MHz, CDCl3) δ 7.97−7.89 (m, 6H), 7.33−7.28 (m, 6H), 7.09−7.03
(m, 4H), 3.91 (s, 9H), 2.62−2.52 (m, 2H), 1.65−1.59 (m, 2H), 1.36−
1.21 (m, 23H), 0.88 (t, 3H); 13C NMR (75 MHz, CDCl3) δ 166.8,
150.9, 142.0, 141.4, 130.8, 130.6, 129.1, 128.2, 128.0, 65.2, 52.1, 35.4,
31.9, 31.3, 29.7, 29.6, 29.49, 29.45, 29.36, 22.7, 14.1; HR-MS (ESI)
calcd for C45H54O6 [M + H+] 691.3993, found 691.3986.
Step 4: To the solution of the above carbamate in EtOH (40 mL)
was added a solution of KOH (3.07 g, 54.98 mmol) in H2O (4 mL).
The mixture was heated at 95 °C for 18 h. The volatiles were removed
and water (100 mL) was added. The product was extracted with Et2O
(3 × 80 mL). The combined ethereal extracts were washed with brine
(150 mL), dried over Na2SO4, and concentrated to give the crude
product as a pink oil. Purification by flash column chromatography
(20% EtOAc in hexane → 8% MeOH in CH2Cl2) provided the amine
1
9 as a light yellow solid (1.20 g, 57% in four steps): H NMR (500
MHz, CDCl3) δ 7.07 (d, J = 8.4 Hz, 2H), 7.01 (d, J = 8.4 Hz, 2H),
6.97−6.93 (m, 6H), 6.58−6.54 (m, 6H), 3.58 (s, 6H), 2.59−2.49 (m,
2H), 1.63−1.57 (m, 2H), 1.35−1.20 (m, 24H), 0.89 (t, J = 6.9 Hz,
3H); 13C NMR (75 MHz, CDCl3) δ 145.4, 144.0, 140.1, 138.4, 132.2,
131.1, 127.3, 114.2, 62.7, 35.7, 32.2, 31.6, 29.92, 29.88, 29.84, 29.76,
29.7, 29.6, 22.9, 14.4; HR-MS (ESI) calcd for C39H51N3 [M + H+]
562.4156, found 562.4159.
General Procedure for COP Synthesis. To a solution of 8b (20
mg, 0.032 mmol) and 2a (30 mg, 0.049 mmol) in 1,2,4-
trichlorobenzene (TCB) (11 mL) was added a solution of TFA
(0.38 μL, 0.0049 mmol) in CHCl3 (100 μL) slowly dropwise. The
solution was stirred at rt for 18 h, at which time 1H NMR spectrum of
the concentrated crude reaction mixture indicated both of the starting
materials were consumed. DIBAL-H (960 μL, 0.96 mmol, 1.0 M in
CH2Cl2) was added. After stirring at rt for 20 min, the reaction was
quenched with MeOH (1 mL), and saturated NaHCO3 (15 mL) was
added. The mixture was stirred at rt for 30 min, and the organic layer
was separated. The aqueous solution was extracted with CHCl3 (3 ×
30 mL). The combined organics were dried over Na2SO4 and
concentrated to give the crude product. Purification by flash column
chromatography (CH2Cl2) provided the pure product COP-15a as a
1
yellow solid (11 mg, 23%): H NMR (500 MHz, THF) δ 8.79 (br s,
Compound 14. To a suspension of compound 13 (2.57 g, 3.72
mmol) in EtOH (40 mL) was added a solution of KOH (3.12 g, 55.8
mmol) in H2O (12 mL). The mixture was refluxed for 16 h, and
cooled to rt. It was then acidified with HCl (1 N, ∼100 mL) and
extracted with EtOAc (3 × 100 mL). The combined organic extracts
were dried over anhydrous Na2SO4, and concentrated to give
compound 14 as a colorless solid (2.37 g, 98%): 1H NMR (500
MHz, DMSO) δ 7.92 (d, J = 8.4 Hz, 6H), 7.35 (d, J = 8.5 Hz, 6H),
7.19 (d, J = 8.4 Hz, 2H), 7.11 (d, J = 8.4 Hz, 2H), 1.61−1.51 (m, 2H),
1.28−1.23 (m, 24H), 0.87 (t, J = 6.6 Hz, 3H); 13C NMR (101 MHz,
CD3OD) δ 169.4, 152.4, 143.7, 142.6, 132.0, 131.9, 130.3, 130.0,
129.2, 66.4, 36.4, 33.2, 33.1, 32.5, 30.81, 30.79, 30.7, 30.6, 30.5, 30.4,
27.5, 23.8, 23.1, 14.5; HR-MS (ESI) calcd for C42H48O6 [M − H−]
647.3378, found 647.3380.
Compound 9. Step 1: A solution of compound 14 (2.37 g, 3.65
mmol) in CH2Cl2 (20 mL) and THF (5 mL) was stirred and cooled at
0 °C. Oxalyl chloride (4.17 g, 32.9 mmol) was added dropwise,
followed by DMF (3 drops) at 0 °C. The mixture was allowed to warm
to rt and stirred for 1 h. TLC showed all the compound 14 was
consumed. The volatiles were evaporated to give light yellow solid
(2.71 g), which was used in the following step without further
purification.
Step 2: A solution of the above acyl chloride (2.71 g) in acetone
(100 mL) was stirred and cooled to 0 °C, as a solution of NaN3 (2.14
g, 32.9 mmol) in H2O (10 mL) was added dropwise. The mixture was
stirred at 0 °C for 1 h. The solvent was evaporated and water (50 mL)
was added. The organic was separated, and the aqueous layer was
extracted with Et2O (5 × 50 mL). The combined organic extracts were
dried over anhydrous Na2SO4 and concentrated to give the crude
product (3.05 g), which was used in the following step without further
purification
Step 3: To the solution of the above acyl azide (3.05 g) in toluene
(40 mL) was added benzyl alcohol (3.55 g, 32.9 mmol). The solution
was refluxed for 2 h, at which point TLC showed complete conversion
of the acyl azide to carbamate. Ethyl acetate (150 mL) was added, and
the solution was washed with saturated NaHCO3 (2 × 100 mL) and
6H), 8.25 (br s, 12H), 8.15 (br s, 6H), 7.82 (s, 3H), 7.77 (s, 3H), 7.66
(s, 3H), 7.01−6.80 (m, 12H), 6.78−6.49 (m, 12H), 5.53−5.13 (m,
6H), 4.33 (d, J = 4.8 Hz, 12H), 2.17−2.10 (m, 4H), 1.35−0.74 (m,
56H), 0.69 (t, J = 7.3 Hz, 18H); 13C NMR (75 MHz, THF) δ 148.0,
144.7, 140.6, 140.4, 133.6, 133.0, 132.9, 132.1, 131.9, 131.8, 131.0,
130.7, 129.3, 127.4, 126.5, 126.4, 125.2, 123.2, 119.2, 113.1, 95.3, 90.3,
48.7, 33.1, 32.0, 31.3, 30.8, 30.6, 30.5, 30.0, 23.7, 23.3, 14.8, 14.6; MS
(MALDI) calcd for C186H162Br6N6 ([M+]) 2960.80, found 2960.75.
COPI-15b. The general procedure for COP synthesis described
above was followed. Compound 8b (11 mg, 0.018 mmol) and 2b (20
mg, 0.027 mmol) were converted to COPI-15b (25 mg, 83%, a yellow
solid) using TFA (0.21 μL, 0.0027 mmol), CHCl3 (6 mL), and
DIBAL-H (540 μL, 0.54 mmol, 1.0 M in CH2Cl2, 0 °C). The physical
1
data for COPI-15b: H NMR (500 MHz, CDCl3) δ 8.79 (br s, 6H),
8.24−8.19 (m, 6H), 8.18−8.14 (m, 6H), 8.09 (s, 6H), 7.80 (br s, J =
13.1 Hz, 6H), 7.68 (br s, 6H), 7.48 (br s, J = 8.8 Hz, 6H), 7.16 (br s,
6H), 6.68 (s, 18H), 4.29 (s, 12H), 3.81 (s, 6H), 2.44 (t, J = 7.1 Hz,
12H), 2.17−2.07 (m, 12H), 1.66−1.60 (m, 12H), 1.51−1.45 (m,
12H), 1.38−1.24 (m, 72H), 1.24−1.15 (m, 12H), 1.06−1.00 (m,
12H), 0.89 (t, J = 6.8 Hz, 18H), 0.76 (t, J = 7.3 Hz, 18H); 13C NMR
(75 MHz, CDCl3) δ 146.4, 140.1, 139.9, 139.2, 133.9, 132.2, 132.0,
131.7, 131.3, 130.8, 128.3, 126.8, 125.4, 125.1, 124.4, 124.1, 118.6,
112.8, 95.3, 91.8, 89.2, 80.0, 49.1, 32.1, 31.2, 29.9, 29.8, 29.5, 29.4,
29.2, 29.0, 22.9, 22.6, 19.7, 14.44, 14.36; MS (MALDI) calcd for
C246H264N6 ([M+]) 3304.09, found 3304.04.
COPII-18. The general procedure for COP synthesis described
above was followed. Compound 9 (15 mg, 0.027 mmol) and
compound 1 (18 mg, 0.040 mmol) were converted to COPII-18 (a
light yellow solid, 25 mg, 78%) using TFA (0.31 μL, 0.004 mmol),
CHCl3 (9 mL), and DIBAL-H (810 μL, 0.81 mmol, 1.0 M in CH2Cl2).
The physical data for COPII-18: 1H NMR (500 MHz, CDCl3) δ 8.98
(s, 6H), 8.10 (d, J = 14.6 Hz, 6H), 7.69 (d, J = 9.0 Hz, 6H), 7.62 (d, J
= 13.1 Hz, 6H), 7.57 (d, J = 8.0 Hz, 12H), 7.52 (d, J = 8.2 Hz, 6H),
7.36 (d, J = 8.7 Hz, 12H), 7.12−7.09 (d, 6H), 7.07 (d, J = 7.9 Hz,
12H), 6.37 (d, J = 13.7 Hz, 12H), 3.85 (br s, 12H), 3.22 (br s, 6H),
2.58−2.45 (m, 4H), 1.61−1.54 (m, 4H), 1.37−1.15 (m, 44H), 0.92 (t,
7398
dx.doi.org/10.1021/jo3011683 | J. Org. Chem. 2012, 77, 7392−7400